On Wednesday 30th October 2024, Bio-Rad Laboratories (NYSE: BIO) will release its highly anticipated third quarter financial results. This important announcement is scheduled to occur after market close.
According to the forecasts of financial experts on Wall Street, the business is expected to reveal an anticipated $1.16 profit per share for the quarter. Additionally, the firm is poised to disclose a quarterly revenue of $628.17 million.
According to the Wall Street analysts projections, the company is expected to generate a total revenue of $2.58 billion for the fiscal year. Additionally, these analysts anticipate that the company will report profit of $9.26 per share during the same period.
During the same quarter of the previous year, the company's earnings report indicated a per-share income of $2.33. Moreover, the company generated a total revenue of $632.12 million during that specific quarter.
The business has scheduled a conference call on 30th October 2024 at 05:00 PM eastern time to discuss Q3 financial results.
Bio-Rad Laboratories (BIO) closed Monday's regular trading session at $328.59, indicating a 2.61 percent advance. During the day, BIO shares traded between $319.75 and $329.34, with a day volume of 178.00 thousand shares.
